Having demonstrated the presence of gut bacteria with cross-reactive capsules in the majority of meningitis patients, we then determined the levels of serum and salivary antibodies against the capsule and the IgA1 protease of the autologous blood isolate. This evidence concerns the gene IGHA1 and meningitis.